+1-888-771-6965
Log In / Register

Your Shopping Cart

Contains 0 items
Total: $0.00
View Shopping Cart
  • fda-import-program-2019-seminar-training
  • raw-material-requirements-health-canada-usp-ep-in-a-cgmp-environment-issues-and-solutions-

Webinars

View More »

Statistical Justification for Using Small Sample Sizes and only 3 Lots in Process or Produ ....

  • John N Zorich
  • Aug 22, 2019

Japan: Regulatory Compliance Requirements for Life Science Products

  • Robert J Russell
  • Aug 23, 2019

Developing Practical and Successful GCP and GVP Audit & Inspection CAPAs

  • Penelope Przekop
  • Aug 26, 2019

State of the Art: Recommendations for writing a thorough SOA and build SOA Libraries for y ....

  • Maria Sanchez
  • Aug 27, 2019

Writing Effective SOPs for the Medical Device and Pharmaceutical Industries

  • Carl Patterson
  • Aug 27, 2019

The Identification and Quantitation of low-level compounds for Impurity and Degradation An ....

  • John Fetzer
  • Aug 27, 2019

Getting to Know FDA Audit Practices and the 10 Most Common Cited GMP Deficiencies

  • Kenneth Christie
  • Aug 27, 2019

Food Allergen Programs - Current Trends, Technologies and Risk Mitigation

  • Michael Brodsky
  • Aug 27, 2019

10 Tips for Successful Hospital Utilization Management: From Foundation to New Trends

  • Beverly Cunningham
  • Aug 28, 2019

Specification and OOS for Pharma, Biopharma and Combination Products

  • Tanvir Mahmud
  • Aug 28, 2019

Pharmaceutical Water System: Design, Testing and Data Management

  • Charity Ogunsanya
  • Aug 29, 2019

What to Expect from FDA's Approach to Regulate Medical Software

  • Dennis Weissman
  • Aug 29, 2019

Comparability Protocols For Approved Drugs

  • Peggy Berry
  • Sep 17, 2019

Technical Writing in an Industrial Environment

  • Robert Peoples
  • Sep 19, 2019

Understanding FDAs Prescription Rules & Regulations – Part 1

  • Sharon W Ayd
  • Sep 24, 2019

Recognizing and Responding to "Red Flags" in Clinical Operations

  • Peggy Berry
  • Oct 8, 2019

Seminars

View More »

Managing Your Complaints and Obstacles in Post-Market Requirements -- Results from Top Medical Device Observations During an Inspection

  • Rita Hoffman
  • San Diego, CA | September 12-13, 2019

Reduce costs for compliance with data integrity: 21 CFR Part 11, SaaS/Cloud, EU GDPR

  • David Nettleton
  • Philadelphia, PA | September 26-27, 2019

21 CFR Part 11 Compliance for SaaS/Cloud Applications

  • David Nettleton
  • Philadelphia, PA | September 26-27, 2019

Designing and Sustaining New and Existing Product Stability Testing Program

  • Charity Ogunsanya
  • Philadelphia, PA | September 26-27, 2019

Raw Material Requirements (Health Canada/USP/EP) in a cGMP Environment - Issues and Solutions

  • Barry A Friedman
  • San Diego, CA | October 3-4, 2019

FDA's New Import Program for 2019 - Strict Precision

  • Casper Uldriks
  • Houston, TX | October 17-18, 2019

PV (Pharmacovigilance) Audit Strategy Planning - A Practical Approach to Design and Implementation

  • Penelope Przekop
  • Boston, MA | October 21-22, 2019

FDA's GMP Expectations for Phase I and First-in-Man Clinical Trials

  • Peggy Berry
  • Boston, MA | November 7-8, 2019

Quality Control Laboratory Compliance - cGMPs and GLPs

  • David L Chesney
  • San Francisco, CA | November 18-19, 2019
  • reduce-costs-for-compliance-with-data-integrity
  • quality-control-laboratory-compliance-cgmps-and-glps

You Recently Viewed